Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT01088386
Zyprexa® Relprevv™ Patient Care Program
Sponsor: Eli Lilly and Company
View on ClinicalTrials.gov
Summary
The goal of the Zyprexa Relprevv Patient Care Program is to mitigate the risk of negative outcomes associated with Zyprexa Relprevv post-injection delirium/sedation syndrome (PDSS).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
4000
Start Date
2010-03-03
Completion Date
2026-06
Last Updated
2026-01-28
Healthy Volunteers
No
Conditions
Locations (1)
United BioSource Corporation
Blue Bell, Pennsylvania, United States